3BAR OR D, LAU E, WINKLER J V. A novel assay for cobait-albumin binding and its potential as a marker for myocardial ischemia preliminary report[J]. J Emerg Med, 2000,19 (4):311-315.
4CONTI C R. Updated pathophysiologic concepts in unstable coronary artery disease[J]. Am Heart J, 2001,141(2):12-14.
5SINHA M K, ROY D, GAZE D C, et al. Role of isehemia modified albumin a new biochemical marker of myocardial ischemia in the early diagnosis of acute coronary syndromes[J]. Emerg Med J, 2004,21(1):29-34.
6Oldgren J, James SK, Siegbahn A, et al. Lipoprotein-associated phospholipase A2 does not predict mortalily or its new ischaemic events in acute coronary syndrome patients[ J]. Eur Heart,2007,28 (5) :699- 704.
7Blankenberg S, Rupprecht HJ,Poirier O,et al. Plasma concentration and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease [ J ]. Circulation, 2003, 107 (10) : 1579-1585.
8Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes [ J ]. JAMA, 2002,106 ( 7 ) : 2894- 2900.
9Robertson L, Grip L, Mattsson HL, et al. Release of protein as well as activity of MMP-9 from unstable avterioscler plaques during percutaneous coronary intervention [J].J Intern Med, 2007,26 ( 2 ) : 659- 667.
10Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risks of coronary atery disease[ J]. JAMA,2001,28 (6) :2136-2142.
